Research on Non-Small Cell Lung Cancer

Focusing on non-small cell lung cancer (NSCLC), this cluster evaluates genetic mutations, treatment responses, and screening techniques. It contributes to the development of targeted therapies and clinical strategies for managing NSCLC.

NSCLC
EGFR mutations
chemotherapy
screening
treatment response
survival

190,842 papers

Parent topic: Cancer Research and Treatment

AI-assisted content · The overview, paper groupings, and influence analysis on this page are AI-generated. They are intended as a starting point for exploring the field and may contain inaccuracies. Report an error

Papers Over Time

1900192019401960198020002020

Top Papers

Activating Mutations In The Epidermal Growth Factor Receptor Underlying Responsiveness Of Non–Small-Cell Lung Cancer To Gefitinib

2004 · 10,495 citations

EGFR Mutations In Lung Cancer: Correlation With Clinical Response To Gefitinib Therapy

2004 · 8,896 citations

Reduced Lung-Cancer Mortality With Low-Dose Computed Tomographic Screening

2011 · 8,768 citations

Nivolumab Versus Docetaxel In Advanced Nonsquamous Non–Small-Cell Lung Cancer

2015 · 8,051 citations

Gefitinib Or Carboplatin–Paclitaxel In Pulmonary Adenocarcinoma

2009 · 7,517 citations

Nivolumab Versus Docetaxel In Advanced Squamous-Cell Non–Small-Cell Lung Cancer

2015 · 7,252 citations

Mutational Landscape Determines Sensitivity To PD-1 Blockade In Non–Small Cell Lung Cancer

2015 · 6,811 citations

Lung Cancer, Cardiopulmonary Mortality, And Long-term Exposure To Fine Particulate Air Pollution

2002 · 6,424 citations

Early Palliative Care For Patients With Metastatic Non–Small-Cell Lung Cancer

2010 · 6,108 citations

Paclitaxel–Carboplatin Alone Or With Bevacizumab For Non–Small-Cell Lung Cancer

2006 · 5,428 citations

Erlotinib In Previously Treated Non–Small-Cell Lung Cancer

2005 · 5,207 citations

Gefitinib Or Chemotherapy For Non–Small-Cell Lung Cancer With Mutated EGFR

2010 · 5,010 citations

Comparison Of Four Chemotherapy Regimens For Advanced Non–Small-Cell Lung Cancer

2002 · 4,902 citations

Identification Of The Transforming EML4–ALK Fusion Gene In Non-Small-Cell Lung Cancer

2007 · 4,782 citations

Comprehensive Molecular Profiling Of Lung Adenocarcinoma

2014 · 4,746 citations

Revisions In The International System For Staging Lung Cancer

1997 · 4,613 citations

Erlotinib Versus Standard Chemotherapy As First-Line Treatment For European Patients With Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer (EURTAC): A Multicentre, Open-Label, Randomised Phase 3 Trial

2012 · 4,554 citations

MET Amplification Leads To Gefitinib Resistance In Lung Cancer By Activating ERBB3 Signaling

2007 · 4,168 citations

Anaplastic Lymphoma Kinase Inhibition In Non–Small-Cell Lung Cancer

2010 · 4,086 citations

EGF Receptor Gene Mutations Are Common In Lung Cancers From “Never Smokers” And Are Associated With Sensitivity Of Tumors To Gefitinib And Erlotinib

2004 · 4,061 citations